Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.90 |
| ▸ | MEN1 | O00255 | 2/20 | 0.90 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.90 |
| ▸ | MMP3 | P08254 | 1/20 | 0.79 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.79 |
| ▸ | ABL1 | P00519 | 2/20 | 0.74 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.74 |
| ▸ | BCR | P11274 | 2/20 | 0.74 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.73 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.73 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.64 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.58 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.55 |
| ▸ | APP | P05067 | 1/20 | 0.54 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30864393 | 1.00 | ESR1 (0.90) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL27738902 | 1.00 | ESR1 (0.90) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL19139538 | 0.97 | ESR1 (0.84) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL699012 | 0.95 | ESR1 (1.00) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL15583815 | 0.92 | MMP3 (0.83) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| Phenol SCHEMBL28118264 | 0.92 | ESR1 (0.75) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL16581374 | 0.92 | MMP3 (0.83) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL20323044 | 0.92 | MMP3 (0.83) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| SCHEMBL4399187 | 0.90 | HSD17B1 (0.91) | ESR1MEN1KMT2AMMP3BCL2L1 | |
| Phenol SCHEMBL9311611 | 0.89 | ESR1 (0.70) | ESR1MEN1KMT2AMMP3BCL2L1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200259089-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMITTING LAYER-FORMING COMPOSITION | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-08-13 | — | — | US | disclosed |
| US-10680186-B2 | Polycyclic aromatic compound and light emitting layer-forming composition | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2020-06-09 | — | — | US | disclosed |
| US-20180040821-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMITTING LAYER-FORMING COMPOSITION | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2018-02-08 | — | — | US | disclosed |
| US-20180040821-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMITTING LAYER-FORMING COMPOSITION | KWANSEI GAKUIN EDUCATIONAL FOUNDATION (JP) | 2018-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10680186-B2 | Polycyclic aromatic compound and light emitting layer-forming composition | C9, TYR, CCNA1 | ESR1 911/4885MEN1 2279/4885KMT2A 206/4885 |
| US-20200259089-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMITTING LAYER-FORMING COMPOSITION | C9, TYR, CCNA1 | ESR1 911/4885MEN1 2279/4885KMT2A 206/4885 |
| US-20180040821-A1 | POLYCYCLIC AROMATIC COMPOUND AND LIGHT EMITTING LAYER-FORMING COMPOSITION | C9, TYR, CCNA1 | ESR1 911/4885MEN1 2279/4885KMT2A 206/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.